Kai Pharmaceuticals

This study tested a single dose of an experimental drug called KAI-1678 in 23 adults with long-term nerve pain after shingles (postherpetic neuralgia). The goal was to see if it could lower pain levels within 6 hours compared to a placebo or an active painkiller. Participants had…

This study tested whether a single dose of KAI-1678, given as an injection under the skin, could reduce pain in people with spinal cord injury. Five adults with long-term spinal cord injury and ongoing nerve pain took part. The main goal was to see if pain levels dropped within 6…